Skip to content

Clinical trials

Completed Phase 2 trials in Bosnia and Herzegovina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Status: Completed Country / region: Bosnia and Herzegovina Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20072
20082
20093
20101
20111
20141
20152
20161
20172
20181
20192
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche5
Pfizer5
Central European Cooperative Oncology Group2
Altavant Sciences GmbH1
Astellas Pharma Inc1
Cantonal Hospital Zenica1
Daiichi Sankyo1
Genfit1
Haemostatix Ltd1
Light Chain Bioscience - Novimmune SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis, Rheumatoid3
Colorectal Neoplasms3
Breast Neoplasms2
Neoplasm Metastasis2
Thromboembolism2
Adenocarcinoma1
Atrial Fibrillation1
Basal Cell Carcinoma1
Cancer Pain1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.